SOURCE: Bio-Imaging Technologies Inc.

February 22, 2007 13:17 ET

Support Product Development in the Pharmaceutical, Biotechnology and Medical Device Industries With Bio-Imaging Technologies Live on MN1.com

NEWTOWN, PA -- (MARKET WIRE) -- February 22, 2007 -- Mark L. Weinstein, President and Chief Executive Officer of Bio-Imaging Technologies, Inc. (NASDAQ: BITI), will be joining Market News First (www.mn1.com) for an exclusive live interview with MN1's Saul Albom. The interview is scheduled for Thursday, Feb. 22, 2007, at 12:30pm CDT.

Operation in the U.S., Bio-Imaging provides services that support product development process of pharmaceutical, biotechnology and medical device industries. It operates in two segments: Pharmaceutical Contract Services and CapMed division. Pharmaceutical contract service segment provides services that support the product development process of the pharmaceutical, biotechnology and medical device industries. CapMed segment provides software application that enables users to manage and store personal health information, like the medical images, drug information, patient education and disease guidelines.

During the interview, Mr. Weinstein will be discussing Bio-Imaging's recently released Fourth Quarter and Year-End 2006 Financial Results. "In 2006 we solidified our core Clinical Trials Business and made good progress in our CapMed Division. We returned the company to profitability and ended the year with a record backlog," stated Mr. Weinstein. "Fourth quarter 2006 service revenues of $8.6 million represented a 7% sequential quarter over quarter increase. The increased profitability on these revenues is a testament to our leverageable expense base that generally provides increasing margins as we grow our revenues."

Join Mr. Weinstein to learn more about the goals of the company, as well as its position in the stock market.

About Bio-Imaging Technologies

Bio-Imaging Technologies, Inc. is a healthcare contract service organization providing services that support the product development process of the pharmaceutical, biotechnology and medical device industries. The Company has specialized in assisting its clients in the design and management of the medical-imaging component of clinical trials since 1990. Bio-Imaging serves its clients on a global basis through its US Core Lab in Newtown, PA, its European Core Lab in Leiden, The Netherlands and its recent acquisition of Theralys SA in Lyon, France. Through its CapMed division, Bio-Imaging provides the Personal HealthKey™ technology and the Personal Health Record (PHR) software allowing patients to better monitor and manage their health care information. Copies of Bio-Imaging Technologies' press releases and other information may be obtained through Bio-Imaging's web site at www.bioimaging.com.

About MN1.com

Market News First is an online, market news provider that brings investors current news on the market. Market News First is the only online, live radio web site that brings real market news to investors and features live interaction with companies from the AMEX, NYSE, NASDAQ, Over the Counter Bulletin Board and the Pink Sheets.

Through daily, live commentary we keep you up to date on the companies you invest in along with what's going on in the stock markets by the second.

Contact Information